Both concurrent and sequential RT combined with IO have different efficacy, but most studies have advocated that RT concurrently combined with PD‐(L)1‐based IO has a better survival benefit in NSCLC BMs, compared with the sequential mode. This evidence concerns the gene CD274 and non-small cell lung carcinoma.